173 related articles for article (PubMed ID: 24786481)
1. Effect of polydimethylsiloxane and ethylcellulose on in vitro permeation of centchroman from its transdermal patches.
Gupta V; Singh S; Srivarstava M; Ahmad H; Pachauri SD; Khandelwal K; Dwivedi P; Dwivedi AK
Drug Deliv; 2016; 23(1):113-22. PubMed ID: 24786481
[TBL] [Abstract][Full Text] [Related]
2. Preparation and evaluation of diltiazem hydrochloride diffusion-controlled transdermal delivery system.
Limpongsa E; Umprayn K
AAPS PharmSciTech; 2008; 9(2):464-70. PubMed ID: 18431661
[TBL] [Abstract][Full Text] [Related]
3. Design, development, physicochemical, and in vitro and in vivo evaluation of transdermal patches containing diclofenac diethylammonium salt.
Arora P; Mukherjee B
J Pharm Sci; 2002 Sep; 91(9):2076-89. PubMed ID: 12210054
[TBL] [Abstract][Full Text] [Related]
4. Influence of the Component Excipients on the Quality and Functionality of a Transdermal Film Formulation.
Saoji SD; Atram SC; Dhore PW; Deole PS; Raut NA; Dave VS
AAPS PharmSciTech; 2015 Dec; 16(6):1344-56. PubMed ID: 25922089
[TBL] [Abstract][Full Text] [Related]
5. A comparison between povidone-ethylcellulose and povidone-eudragit transdermal dexamethasone matrix patches based on in vitro skin permeation.
Mukherjee B; Mahapatra S; Gupta R; Patra B; Tiwari A; Arora P
Eur J Pharm Biopharm; 2005 Apr; 59(3):475-83. PubMed ID: 15760728
[TBL] [Abstract][Full Text] [Related]
6. Development of carvedilol transdermal patches: evaluation of physicochemical, ex vivo and mechanical properties.
Gannu R; Vishnu YV; Kishan V; Rao YM
PDA J Pharm Sci Technol; 2008; 62(6):391-401. PubMed ID: 19634343
[TBL] [Abstract][Full Text] [Related]
7. In vitro evaluation of transdermal patches of flurbiprofen with ethyl cellulose.
Idrees A; Rahman NU; Javaid Z; Kashif M; Aslam I; Abbas K; Hussain T
Acta Pol Pharm; 2014; 71(2):287-95. PubMed ID: 25272649
[TBL] [Abstract][Full Text] [Related]
8. Formulation design and development of matrix diffusion controlled transdermal drug delivery of glimepiride.
Akram MR; Ahmad M; Abrar A; Sarfraz RM; Mahmood A
Drug Des Devel Ther; 2018; 12():349-364. PubMed ID: 29503528
[TBL] [Abstract][Full Text] [Related]
9. PREPARATION, IN VITRO AND IN VIVO CHARACTERIZATION OF HYDROPHOBIC PATCHES OF A HIGHLY WATER SOLUBLE DRUG FOR PROLONGED PLASMA HALF LIFE: EFFECT OF PERMEATION ENHANCERS.
Yaqoob A; Ahmad M; Mahmood A; Sarfraz RM
Acta Pol Pharm; 2016 Nov; 73(6):1639-1648. PubMed ID: 29634120
[TBL] [Abstract][Full Text] [Related]
10. Formulation and evaluation of anti-rheumatic dexibuprofen transdermal patches: a quality-by-design approach.
Akhlaq M; Arshad MS; Mudassir AM; Hussain A; Kucuk I; Haj-Ahmad R; Rasekh M; Ahmad Z
J Drug Target; 2016 Aug; 24(7):603-12. PubMed ID: 26586147
[TBL] [Abstract][Full Text] [Related]
11. Effect of concurrently coadministered drugs on the pharmacokinetic/pharmacodynamic profile of centchroman, a nonsteroidal oral contraceptive, in rats.
Kumar V; Lal J; Singh MM; Gupta RC
Contraception; 2006 Aug; 74(2):165-73. PubMed ID: 16860055
[TBL] [Abstract][Full Text] [Related]
12. Novel biomaterial for transdermal application: in vitro and in vivo characterization.
Mundada AS; Avari JG
Drug Deliv; 2011 Aug; 18(6):424-31. PubMed ID: 21554152
[TBL] [Abstract][Full Text] [Related]
13. Designing and characterizing of tramadol hydrochloride transdermal patches prepared with Ficus carica fruit mucilage and povidone.
Ahad HA; Ishaq BM; Shaik M; Bandagisa F
Pak J Pharm Sci; 2016 May; 29(3):945-51. PubMed ID: 27166538
[TBL] [Abstract][Full Text] [Related]
14. Skin permeation of propranolol from polymeric film containing terpene enhancers for transdermal use.
Amnuaikit C; Ikeuchi I; Ogawara K; Higaki K; Kimura T
Int J Pharm; 2005 Jan; 289(1-2):167-78. PubMed ID: 15652209
[TBL] [Abstract][Full Text] [Related]
15. Centchroman: A safe reversible postcoital contraceptive with curative and prophylactic activity in many disorders.
Kamboj VP; Ray S; Anand N
Front Biosci (Elite Ed); 2018 Jan; 10(1):1-14. PubMed ID: 28930603
[TBL] [Abstract][Full Text] [Related]
16. Development and evaluation of nefopam transdermal matrix patch system in human volunteers.
De P; Damodharan N; Mallick S; Mukherjee B
PDA J Pharm Sci Technol; 2009; 63(6):537-46. PubMed ID: 20169860
[TBL] [Abstract][Full Text] [Related]
17. Glibenclamide transdermal patches: physicochemical, pharmacodynamic, and pharmacokinetic evaluations.
Mutalik S; Udupa N
J Pharm Sci; 2004 Jun; 93(6):1577-94. PubMed ID: 15124215
[TBL] [Abstract][Full Text] [Related]
18. Development of matrix-type transdermal delivery of lornoxicam: in vitro evaluation and pharmacodynamic and pharmacokinetic studies in albino rats.
Baviskar DT; Parik VB; Jain DJ
PDA J Pharm Sci Technol; 2013; 67(1):9-22. PubMed ID: 23385560
[TBL] [Abstract][Full Text] [Related]
19. Development of domperidone bilayered matrix type transdermal patches: physicochemical, in vitro and ex vivo characterization.
Madishetti SK; Palem CR; Gannu R; Thatipamula RP; Panakanti PK; Yamsani MR
Daru; 2010; 18(3):221-9. PubMed ID: 22615620
[TBL] [Abstract][Full Text] [Related]
20. Transmucosal delivery of domperidone from bilayered buccal patches: in vitro, ex vivo and in vivo characterization.
Palem CR; Gannu R; Doodipala N; Yamsani VV; Yamsani MR
Arch Pharm Res; 2011 Oct; 34(10):1701-10. PubMed ID: 22076770
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
